#678136
Heipitíteas eansótach
Rift Valley fever
Heipitíteas eansótach
Rift Valley fever
Heipitíteas eansótach
Rift Valley fever
Heipitíteas eansótach;
Rift Valley fever virus;
42.Heipitíteas eansótach;
42.Rift Valley fever virus;
Heipitíteas eansótach;
Rift Valley fever virus;
Bunaítear leis seo saotharlann tagartha an Aontais Eorpaigh maidir leis an heipitíteas eansótach.
The European Union reference laboratory for Rift Valley fever is hereby established.
Mearmheasúnú riosca: Ráig den heipitíteas eansótach in Mayotte na Fraince – 7 Márta 2019.
Rapid risk assessment: Rift Valley fever outbreak in Mayotte, France – 7 March 2019.
Heipitíteas eansótach;
Rift Valley fever virus;
lena n-ainmnítear saotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach
designating the European Union reference laboratory for Rift Valley fever
Ainmnítear an tsaotharlann seo a leanas mar shaotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach:
The following laboratory is designated as the European Union reference laboratory for Rift Valley fever:
Heipitíteas eansótach;
Rift Valley fever virus;
Heipitíteas eansótach;
Rift Valley fever virus;
Ina theannta sin, ghlac an tÚdarás Eorpach um Shábháilteacht Bia (EFSA) tuairim eolaíoch maidir leis an heipitíteas eansótach an 23 Eanáir 2020, tuairim inar cuireadh in iúl nár cheart neamhaird a thabhairt ar an mbaol go leathfadh an heipitíteas eansótach isteach i dtíortha atá i gcomharsanacht an Aontais ná ar an mbaol go dtabharfaí veicteoirí ionfhabhtaithe isteach san Aontas.
In addition, the European Food Safety Authority (EFSA) adopted a scientific opinion on RVF on 23 January 2020, indicating that the risk of spread of RVF into countries neighbouring the Union and the risk of possible introduction of infected vectors into the Union should not be ignored.
Tar éis saotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach a bhunú, agus i gcomhréir le hAirteagal 93(2), pointe (a), de Rialachán (AE) 2017/625, lean an Coimisiún próiseas roghnúcháin poiblí chun saotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach a ainmniú.
Following the establishment of the European Union reference laboratory for Rift Valley fever, and in accordance with Article 93(2), point (a), of Regulation (EU) 2017/625, the Commission followed a public selection process for the designation of the European Union reference laboratory for Rift Valley fever.
lena bhforlíontar Rialachán (AE) 2017/625 ó Pharlaimint na hEorpa agus ón gComhairle trí shaotharlann tagartha an Aontais Eorpaigh a bhunú le haghaidh an heipitíteas eansótach
supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever
Rátaí arda mairfeachta agus mortlaíochta mortlaíocht laonna nuabheirthe, sin í an tsaintréith a bhaineann leis an heipitíteas eansótach i gcás an athchogantaigh clóis.
RVF is characterised by high rates of abortion and neonatal mortality in domestic ruminants.
Tá an heipitíteas eansótach ar liosta na hEagraíochta Domhanda um Shláinte Ainmhithe (OIE) de ghalair ainmhíocha is gá a chur in iúl.
RVF is on the list of notifiable animal diseases of the World Organisation for Animal Health (OIE).
Níl saotharlann tagartha de chuid an Aontais Eorpaigh bunaithe ag an Aontas go fóill maidir leis an heipitíteas eansótach.
So far, the Union has not established a European Union reference laboratory for RVF.
Le Rialachán Tarmligthe (AE) 2021/2156 ón gCoimisiún, bunaíodh saotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach.
Commission Delegated Regulation (EU) 2021/2156 established the European Union reference laboratory for Rift Valley fever.
Ceapadh coiste meastóireachta agus roghnúcháin don phróiseas roghnúcháin poiblí chun saotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach a ainmniú.
An evaluation and selection committee was appointed for the public selection process for the designation of the European Union reference laboratory for Rift Valley fever.
Dá bhrí sin, ba cheart an tsaotharlann Iodálach Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise “G. Caporale” a ainmniú mar shaotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach.
The Italian laboratory Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise ‘G. Caporale’ should therefore be designated as the European Union reference laboratory for Rift Valley fever.
Ba cheart an Rialachán seo a bheith infheidhme ón 1 Eanáir 2023, an dáta ar cheart do shaotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach tús a chur lena gníomhaíochtaí.
This Regulation should be applicable from 1 January 2023, the date when the European Union reference laboratory for Rift Valley fever should commence its activities.
Rialachán Cur Chun Feidhme (AE) 2022/2304 ón gCoimisiún an 24 Samhain 2022 lena n-ainmnítear saotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2022/2304 of 24 November 2022 designating the European Union reference laboratory for Rift Valley fever is to be incorporated into the EEA Agreement.
An galar veicteoir-iompartha zónóiseach heipitíteas eansótach (RVF), galar a bhíonn ar an athchogantach fiáin agus ar an athchogantach clóis, is galar é atá ag teacht chun cinn, is víreas is cúis leis, agus d’fhéadfadh sé gur bagairt trasteorann a bheadh ann.
Rift Valley fever (RVF) is an emerging zoonotic vector-borne disease of wild and domestic ruminants caused by a virus and representing a potential cross-border threat.
An baol atá ann go dtiocfadh an heipitíteas eansótach isteach san Aontas, is rud é a fhágann gur cheart don Aontas bearta leordhóthanacha faireachais agus rialaithe i gcoinne an ghalair sin a bhunú, rud atá i gcomhréir le Rialachán (AE) 2016/429 ó Pharlaimint na hEorpa agus ón gComhairle lena mbunaítear creat reachtach um chosc agus rialú galar liostaithe.
The risk of RVF entering the Union means that the Union should establish adequate surveillance and control measures against this disease, in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council, which establishes a legislative framework for the prevention and control of listed diseases.
I gcomhréir leis an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) 2018/1882 ón gCoimisiún, meastar gur galar de na catagóirí A, D agus E atá sa heipitíteas eansótach, agus gur gá a luaithe a bhraitear é dul i muinín bearta díothaithe ina leith.
In accordance with the Annex to Commission Implementing Regulation (EU) 2018/1882, RVF is considered as a category A, D and E disease, for which immediate eradication measures are to be taken as soon as it is detected.
Dá bhrí sin, ba cheart saotharlann tagartha de chuid an Aontais Eorpaigh maidir leis an heipitíteas eansótach a bhunú leis an Rialachán seo, saotharlann a rannchuideodh le héifeachtacht rialuithe oifigiúla a áirithiú agus le cúnamh do shaotharlanna oifigiúla a chomhordú,
This Regulation should therefore establish a European Union reference laboratory for RVF to contribute to ensure the effectiveness of official controls and to coordinate assistance to official laboratories,
an galar crúibe is béil, ionfhabhtú le heipitíteas eansótach, ionfhabhtú le plá na n-athchogantach beag, bolgach caorach nó bolgach gabhar, pliúrainiúmóine tógálach den chineál gabhair, Mycobacterium tuberculosis complex (M.bovis, M.caprae agus M.tuberculosis) ná ionfhabhtú le Brucella abortus, B. melitensis agus B. suis, ná
foot and mouth disease, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox, contagious caprine pleuropneumonia, Mycobacterium tuberculosis complex (M.bovis, M.caprae and M.tuberculosis) and infection with Brucella abortus, B. melitensis and B. suis, and
nár tuairiscíodh ionfhabhtú le víreas phlá na mbó, ionfhabhtú le heipitíteas eansótach, ionfhabhtú le plá na n-athchogantach beag, bolgach caorach nó bolgach gabhar ná pliúrainiúmóine tógálach den chineál gabhair ar feadh 12 mhí ar a laghad roimh dháta seolta na n-ainmhithe chuig an Aontas agus le linn na tréimhse sin:
in which infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that period:
nár tuairiscíodh timpeall uirthi, i limistéar dar ga 10 km, lena n-áirítear i gcás inarb iomchuí críoch tíre comharsanaí, gurbh ann do na galair liostaithe seo a leanas sna 30 lá ar a laghad roimh dháta seolta na n-ainmhithe chuig an Aontas: an galar crúibe is béil, ionfhabhtú le heipitíteas eansótach, ionfhabhtú le plá na n-athchogantach beag, bolgach caorach nó bolgach gabhar agus pliúrainiúmóine tógálach den chineál gabhair.
in and around which, in an area with a 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia.
Tá Rialachán Tarmligthe (AE) 2021/2156 ón gCoimisiún an 17 Meán Fómhair 2021 lena bhforlíontar Rialachán (AE) 2017/625 ó Pharlaimint na hEorpa agus ón gComhairle trí shaotharlann tagartha an Aontais Eorpaigh a bhunú le haghaidh an heipitíteas eansótach le hionchorprú i gComhaontú LEE.
Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever is to be incorporated into the EEA Agreement.
32021 R 2156: Rialachán Tarmligthe (AE) 2021/2156 ón gCoimisiún an 17 Meán Fómhair 2021 lena bhforlíontar Rialachán (AE) 2017/625 ó Pharlaimint na hEorpa agus ón gComhairle trí shaotharlann tagartha an Aontais Eorpaigh a bhunú le haghaidh an heipitíteas eansótach (IO L 436, 7.12.2021, lch. 26).
32021 R 2156: Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (OJ L 436, 7.12.2021, p. 26).
Rialachán Tarmligthe (AE) 2021/2156 ón gCoimisiún an 17 Meán Fómhair 2021 lena bhforlíontar Rialachán (AE) 2017/625 ó Pharlaimint na hEorpa agus ón gComhairle trí shaotharlann tagartha an Aontais Eorpaigh a bhunú le haghaidh an heipitíteas eansótach (IO L 436, 7.12.2021, lch. 26).
Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (OJ L 436, 7.12.2021, p. 26).
32022 R 2304: Rialachán Cur Chun Feidhme (AE) 2022/2304 ón gCoimisiún an 24 Samhain 2022 lena n-ainmnítear saotharlann tagartha an Aontais Eorpaigh le haghaidh heipitíteas eansótach (IO L 305, 25.11.2022, lch. 51).
32022 R 2304: Commission Implementing Regulation (EU) 2022/2304 of 24 November 2022 designating the European Union reference laboratory for Rift Valley fever (OJ L 305, 25.11.2022, p. 51).